![]() This reflects the current scientific consensus that these can be incorporated within a single, dimensional condition, with variable levels of symptom severity in two core domains: (i) deficits in social communication and social interaction (ii) restricted repetitive behaviours, interests, and activities. Secondly, DSM-5 no longer divides autism into separate disorders as was previously the case in DSM-IV-TR and International Classification of Disorders-10 (ICD-10). The classification also includes intellectual disability (intellectual developmental disorder), communication disorders, attention-deficit/hyperactivity disorder, specific learning disorder, and motor disorders. This is a group of conditions, usually evident in the pre-school years, characterised by specific developmental impairments in cognitive, psychological, communication, social, adaptive, and/or motor functioning. Instead, autism is included within the domain of “Neurodevelopmental Disorders”. įirstly, although in certain European countries, autism still remains in the category of “psychotic disorders”, DSM-5 makes it clear that autism is not a psychotic disorder. We focussed on clinical research updates published during the 3 years prior to submitting the final draft of this document and, in addition, we consulted existing clinical guidelines from Spain, United Kingdom, United States of America, Australia, and Scotland/United Kingdom. ![]() The emphasis was on European clinical research, but also included key international contributions. Consequently, the aim is not to make specific recommendations for the use of particular interventions or assessment methodologies but rather to provide general guidance, based on a combination of information from randomised and non-randomised trials, expert opinion, and other existing international guidelines.ĭuring the period from June 2018 to April 2020, a narrative review of papers published in English on evidence-based diagnostic assessments and treatments across the life cycle of people with autism Footnote 1 was conducted. It was not possible, within the scope of the present article, to complete systematic reviews and/or meta-analyses of all the issues related to autism covered here. ![]() The primary goal of this document is to disseminate information that can be adopted for use in regular clinical practice across Europe and to present clinicians and educators with evidence-based advice on core and minimum standards for good practice in the assessment and treatment of autistic people of all ages. The resulting draft document was reviewed by members of the ESCAP Clinical Division and, following some revisions, was subsequently endorsed by Board of ESCAP on. and P.H.) as the ESCAP ASD working party and instructed them to produce the Practice Guidance document. In June 2018, the Board appointed three experts (J.F., A.H. ![]() The first author (J.F.) was designated, in July 2015, as the ESCAP Autism Field Advisor, with the brief of considering the setting up of European autism guidelines.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |